Content Packages Accelerate MBR Creation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Content Packages Accelerate MBR Creation


Pharmaceutical Technology
Volume 38, Issue 2, pp. 12
Werum Software & Systems has expanded its PAS-X content packages with PAS-X MBR Design Elements content packages. The PAS-X MBR Design Elements Content Packages accelerate the creation of master batch records (MBRs) and help to assure higher quality MBR design in the configured system. The MBR Design Elements are templates for the creation of MBRs for specific processes in pharmaceutical and biopharmaceutical production such as granulation, IPC testing, or reconciliation. The Design Elements focus on the most efficient use of PAS-X functionality MBR, and are designed to operate with with PAS-X manufacturing execution system software. They are part of specific libraries available for all major manufacturing types, such as solids, liquids, and packaging. In addition, Uiversal Elements cover general processes that are not related to specific manufacturing types. The content packages provide a framework for standardizing processes within or between different plants.

Werum Software & Systems AG

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: Pharmaceutical Technology,
Click here